Displaying 5 (all) recruiting clinical trials.
-
Prospective Databased of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
The purpose of this study is to better understand how well Cryo Ablation treats prostate cancer and the long-term effects of this treatment of sexual ... -
A Parallel-Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
If you have been diagnosed with advanced prostate cancer with high levels of DickkopM (DKK1), you may qualify for this Phase 1b/2a study investigating ... -
Metformin Prostate Cancer Adjuvant Trial
The purpose of the study is to determine the safety and effectiveness of Metformin can increase Prostate Specific Antigen (PSA) doubling time for patients with ... -
A Phase 1b/2 Open-Label Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer
The purpose of the study is to determine the safety and efficacy of the treatments: AB928, a novel adenosine receptor blocker, plus zimberelimab, an anti-PD1 ... -
Phase 3 Randomized Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)
The purpose of the trial is to determine the safety and efficacy of the pembrolizumab plus enzalutamide plus ADT versus placebo plus enzalutamide plus androgen ...